Skip to content

The Impact of a Heart Failure Review on Self-Care Knowledge, Adherence and Clinical Outcomes

The Impact of a Heart Failure Review on Self-Care Knowledge, Adherence and Clinical Outcomes

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02415751
Enrollment
57
Registered
2015-04-14
Start date
2015-06-30
Completion date
2019-01-22
Last updated
2019-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure

Brief summary

This study is assessing the effects of a new heart failure self-care education program in the Nebraska Heart Institute Heart Improvement Clinic. The new education program will consist of an initial intensive self-care education session with the Principal Investigator or her nurse practitioner. Topics to be discussed include medications, sodium and fluid consumption, alcohol restriction, exercise, preventive behaviors, and monitoring of signs and symptoms. As recommended in the ACCF/AHA guidelines, this education will be repeated on an annual basis as studies have shown that the impact of HF education is not always durable and must be a continual process. This study will assess the impact of this review on their medication knowledge, disease state knowledge, quality of life, disease state progression and clinical outcomes such as ejection fraction and number of hospitalizations.

Detailed description

This is an observational study as all patients in the heart failure clinic, regardless of whether or not they will choose to be in the study, will receive heart failure self-care education from now on.

Interventions

It is defined as a naturalistic decision-making process that patients use in the choice of behaviors that maintain physiological stability (symptom monitoring and treatment adherence) and the response to symptoms when they occur (Riegel 2004). This includes following advice regarding medications, sodium and water consumption, alcohol restriction, exercise, preventive behaviors, and monitoring of signs and symptoms.

Sponsors

CHI Nebraska Heart
CollaboratorUNKNOWN
Creighton University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Males and females ages 19 and older * Able to speak, read and understand English and able to understand and provide informed consent * Diagnosis of cardiomyopathy and/or HF, preserved or reduced ejection fraction

Exclusion criteria

* Patients not-responsible for self-care. * Inability to provide written informed consent. * Co-morbid condition with an expected survival of less than six months.

Design outcomes

Primary

MeasureTime frame
number of hospitalizations12 months

Secondary

MeasureTime frameDescription
ejection fraction12 months
change in heart failure medication knowledge12 monthsAdapted from the Atlanta Heart Failure Knowledge Test V2 (AHFKT-VT) (Miller Reilly C 2009) Grading: 1 point for correct answer, 0 points for incorrect or skipped Total points and divide by 6 for percentage score

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026